Nwam LLC Abbott Laboratories Transaction History

Nwam LLC

$1.6 Billion
Q3 2024

A detailed history of Nwam LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Nwam LLC holds 20,597 shares of ABT stock, worth $2.43 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

20,597

Holding current value

$2.43 Million

% of portfolio

0.15%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$100.07 - $118.13 $2.06 Million - $2.43 Million	20,597 New	20,597 $2.35 Million
Q1 2024 May 09, 2024	SELL	$109.52 - $120.96 $655,696 - $724,187	-5,987 Reduced 48.84%	6,271 $712,000
Q4 2023 Feb 14, 2024	SELL	$90.19 - $110.4 $29,672 - $36,321	-329 Reduced 2.61%	12,258 $1.35 Million
Q3 2023 Oct 31, 2023	SELL	$95.53 - $114.62 $68,495 - $82,182	-717 Reduced 5.39%	12,587 $1.22 Million
Q2 2023 Aug 09, 2023	BUY	$100.78 - $112.29 $829,721 - $924,483	8,233 Added 162.35%	13,304 $1.45 Million
Q1 2023 May 12, 2023	SELL	$96.86 - $114.01 $731,777 - $861,345	-7,555 Reduced 59.84%	5,071 $513,000
Q4 2022 Feb 07, 2023	SELL	$95.06 - $111.52 $118,064 - $138,507	-1,242 Reduced 8.96%	12,626 $1.39 Million
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $13,159 - $15,236	136 Added 0.99%	13,868 $1.34 Million
Q2 2022 Aug 10, 2022	SELL	$102.07 - $123.37 $7,246 - $8,759	-71 Reduced 0.51%	13,732 $1.5 Million
Q1 2022 May 12, 2022	BUY	$114.02 - $139.04 $144,235 - $175,885	1,265 Added 10.09%	13,803 $1.63 Million
Q4 2021 Feb 10, 2022	BUY	$115.53 - $141.46 $94,272 - $115,431	816 Added 6.96%	12,538 $1.77 Million
Q3 2021 Nov 03, 2021	SELL	$116.66 - $129.06 $18,432 - $20,391	-158 Reduced 1.33%	11,722 $1.39 Million
Q2 2021 Aug 04, 2021	SELL	$105.79 - $124.53 $5,183 - $6,101	-49 Reduced 0.41%	11,880 $1.38 Million
Q1 2021 Apr 23, 2021	SELL	$108.84 - $128.23 $27,754 - $32,698	-255 Reduced 2.09%	11,929 $1.43 Million
Q4 2020 Jan 22, 2021	BUY	$105.0 - $114.42 $19,425 - $21,167	185 Added 1.54%	12,184 $1.33 Million
Q3 2020 Oct 16, 2020	SELL	$91.64 - $111.29 $173,657 - $210,894	-1,895 Reduced 13.64%	11,999 $1.31 Million
Q2 2020 Jul 21, 2020	BUY	$76.57 - $98.0 $91,883 - $117,600	1,200 Added 9.45%	13,894 $1.27 Million
Q1 2020 Apr 16, 2020	SELL	$62.82 - $91.86 $165,593 - $242,142	-2,636 Reduced 17.2%	12,694 $1 Million
Q4 2019 Jan 23, 2020	SELL	$78.51 - $87.4 $495,790 - $551,931	-6,315 Reduced 29.18%	15,330 $1.33 Million
Q3 2019 Oct 15, 2019	BUY	$81.84 - $88.74 $1.32 Million - $1.43 Million	16,102 Added 290.49%	21,645 $1.81 Million
Q2 2019 Jul 18, 2019	SELL	$72.88 - $85.0 $2,186 - $2,550	-30 Reduced 0.54%	5,543 $466,000
Q1 2019 Apr 17, 2019	BUY	$66.22 - $80.06 $37,745 - $45,634	570 Added 11.39%	5,573 $446,000
Q3 2018 Oct 09, 2018	SELL	$60.81 - $73.36 $1,277 - $1,540	-21 Reduced 0.42%	5,003 $367,000
Q2 2018 Jul 16, 2018	SELL	$57.57 - $63.54 $7,196 - $7,942	-125 Reduced 2.43%	5,024 $306,000
Q1 2018 Apr 16, 2018	SELL	$56.27 - $63.62 $99,991 - $113,052	-1,777 Reduced 25.66%	5,149 $309,000
Q4 2017 Feb 07, 2018	SELL	$53.68 - $57.47 $4,670 - $4,999	-87 Reduced 1.24%	6,926 $395,000
Q3 2017 Nov 01, 2017	BUY	$48.06 - $53.64 $337,044 - $376,177	7,013	7,013 $374,000

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

Vanguard Group Inc Valley Forge, PA

168M
Shares

$19.8 Billion
0.35% of portfolio
Black Rock Inc. New York, NY

131M
Shares

$15.5 Billion
0.31% of portfolio
State Street Corp Boston, MA

76.7M
Shares

$9.06 Billion
0.36% of portfolio
Capital International Investors Los Angeles, CA

65.7M
Shares

$7.77 Billion
1.49% of portfolio
Capital Research Global Investors Los Angeles, CA

53.3M
Shares

$6.3 Billion
1.31% of portfolio

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $207B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nwam LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nwam LLC with notifications on news.

Account